Financial Ratios Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:27 2025-06-20 am EDT			5-day change	1st Jan Change
259.30 ^CHF	-0.27%		-3.86%	+1.49%

01:41am	Roche's Investigational Therapy for Lymphoma Demonstrates 'Significant' Improvement	MT
Jun. 20	Roche's Lymphoma Treatment Shows Promise in Late-Stage Trial	DJ

d7d4d8f8e98.Sty2tb8yk-GDv_GIlcgnghL0Y36_r8MSnca0H4HvkM4.Dar-8N1twJjn7cSwpv9L6CCZVT3l_60_0p-ZR_eA-Y0EhsCN0nD81s7cgg

Published financial data: ROCHE HOLDING AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	60.34B	65.85B	66.43B	58.72B	60.5B
Other Revenues, Total	-	-	-	1.72B	1.9B
Total Revenues	60.34B	65.85B	66.43B	60.44B	62.4B
Cost of Goods Sold, Total	15.86B	19.36B	18.6B	15.6B	15.73B
Gross Profit	44.48B	46.49B	47.83B	44.84B	46.66B
Selling General & Admin Expenses, Total	11.95B	11.98B	12.05B	13.49B	13.67B
R&D Expenses	12.57B	14.02B	14.4B	13.54B	13.37B
Other Operating Expenses	265M	238M	192M	34M	1M
Other Operating Expenses, Total	24.78B	26.24B	26.64B	27.06B	27.05B
Operating Income	19.7B	20.25B	21.19B	17.78B	19.62B
Interest Expense, Total	-438M	-342M	-608M	-828M	-1.25B
Interest And Investment Income	16M	-	40M	195M	260M
Net Interest Expenses	-422M	-342M	-568M	-633M	-988M
Income (Loss) On Equity Invest.	-1M	-2M	-41M	-32M	-45M
Currency Exchange Gains (Loss)	-206M	-232M	-278M	-243M	-291M
Other Non Operating Income (Expenses)	-5M	3M	-90M	-14M	-20M
EBT, Excl. Unusual Items	19.06B	19.68B	20.21B	16.86B	18.27B
Restructuring Charges	-909M	-1.36B	-969M	-2.04B	-1.89B
Merger & Related Restructuring Charges	-9M	-55M	38M	-25M	-79M
Impairment of Goodwill	-247M	-	-	-591M	-3.21B
Gain (Loss) On Sale Of Investments	171M	-89M	-85M	5M	35M
Gain (Loss) On Sale Of Assets	-	-	-	569M	384M
Asset Writedown	-435M	-634M	-2.87B	-637M	-1.47B
Legal Settlements	345M	-122M	45M	172M	-83M
Other Unusual Items	-14M	-20M	-43M	-233M	-163M
EBT, Incl. Unusual Items	17.96B	17.4B	16.33B	14.08B	11.79B
Income Tax Expense	2.9B	2.46B	2.8B	1.72B	2.61B
Earnings From Continuing Operations	15.07B	14.94B	13.53B	12.36B	9.19B
Net Income to Company	15.07B	14.94B	13.53B	12.36B	9.19B
Minority Interest	-773M	-1B	-1.11B	-860M	-910M
Net Income - (IS)	14.3B	13.93B	12.42B	11.5B	8.28B
Net Income to Common Incl Extra Items	14.3B	13.93B	12.42B	11.5B	8.28B
Net Income to Common Excl. Extra Items	14.3B	13.93B	12.42B	11.5B	8.28B
Per Share Items
Net EPS - Basic	16.72	16.39	15.53	14.39	10.39
Basic EPS - Continuing Operations	16.72	16.39	15.53	14.39	10.39
Basic Weighted Average Shares Outstanding	855M	850M	800M	799M	797M
Net EPS - Diluted	16.52	16.2	15.37	14.31	10.31
Diluted EPS - Continuing Operations	16.52	16.2	15.37	14.31	10.31
Diluted Weighted Average Shares Outstanding	865M	860M	808M	804M	802M
Normalized Basic EPS	13.03	13.29	14.4	12.11	13.19
Normalized Diluted EPS	12.88	13.13	14.26	12.03	13.11
Dividend Per Share	9.1	9.3	9.5	9.6	9.7
Payout Ratio	53.86	55.8	59.95	66.01	92.42
American Depositary Receipts Ratio (ADR)	0.12	0.12	0.12	0.12	0.12
Supplemental Items
EBITDA	23.9B	24.33B	24.69B	20.92B	22.72B
EBITA	21.45B	21.81B	22.12B	18.5B	20.36B
EBIT	19.7B	20.25B	21.19B	17.78B	19.62B
EBITDAR	23.99B	24.42B	24.78B	21B	22.8B
Total Revenues (As Reported)	60.34B	65.85B	66.43B	60.44B	62.4B
Effective Tax Rate - (Ratio)	16.13	14.16	17.12	12.22	22.1
Total Current Taxes	3.51B	2.62B	4.45B	2.83B	4.32B
Total Deferred Taxes	-610M	-156M	-1.66B	-1.11B	-1.72B
Normalized Net Income	11.14B	11.3B	11.52B	9.68B	10.51B
Interest on Long-Term Debt	27M	24M	20M	31M	49M
Non-Cash Pension Expense	77M	23M	45M	123M	119M
Supplemental Operating Expense Items
Selling and Marketing Expenses	9.39B	9.48B	9.58B	-	-
General and Administrative Expenses	2.46B	2.42B	2.39B	-	-
Research And Development Expense From Footnotes	13.01B	14.8B	16.02B	14.2B	15.3B
Net Rental Expense, Total	94M	87M	87M	82M	80M
Imputed Operating Lease Interest Expense	21.25M	9.92M	14.28M	18.88M	23.76M
Imputed Operating Lease Depreciation	72.75M	77.08M	72.72M	63.12M	56.24M
Stock-Based Comp., COGS (Total)	110M	106M	106M	86M	94M
Stock-Based Comp., R&D Exp. (Total)	300M	277M	330M	385M	394M
Stock-Based Comp., S&M Exp. (Total)	151M	140M	155M	-	-
Stock-Based Comp., G&A Exp. (Total)	152M	140M	147M	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	359M	367M
Total Stock-Based Compensation	713M	663M	738M	830M	855M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	5.73B	6.85B	4.99B	5.38B	6.98B
Short Term Investments	6.6B	6.18B	4.78B	5.13B	10.34B
Trading Asset Securities, Total	20M	4M	1M	2M	16M
Total Cash And Short Term Investments	12.34B	13.03B	9.77B	10.51B	17.33B
Accounts Receivable, Total	10.54B	11.35B	12.21B	11.55B	11.92B
Other Receivables	1.16B	1.23B	1.43B	1.32B	1.47B
Notes Receivable	-	45M	33M	55M	66M
Total Receivables	11.7B	12.63B	13.67B	12.92B	13.46B
Inventory	7.19B	7.72B	8.6B	7.75B	7.61B
Prepaid Expenses	1.15B	1.87B	1.2B	1.14B	1.22B
Restricted Cash	-	23M	198M	61M	22M
Other Current Assets, Total	553M	359M	376M	1.06B	387M
Total Current Assets	32.94B	35.63B	33.82B	33.45B	40.04B
Gross Property Plant And Equipment	45.66B	48.2B	49.41B	46.2B	49.38B
Accumulated Depreciation	-22.39B	-23.79B	-25.2B	-23.26B	-25.64B
Net Property Plant And Equipment	23.27B	24.41B	24.21B	22.94B	23.74B
Long-term Investments	1.28B	1.07B	971M	789M	858M
Goodwill	9.25B	10.81B	10.82B	9.39B	7.88B
Other Intangibles, Total	12.02B	12.12B	9.68B	14.83B	17.3B
Accounts Receivable Long-Term	37M	36M	26M	19M	31M
Loans Receivable Long-Term	8M	7M	7M	7M	7M
Deferred Tax Assets Long-Term	5.46B	5.58B	6.43B	6.88B	8.57B
Other Long-Term Assets, Total	1.88B	2.66B	2.19B	2.17B	3.38B
Total Assets	86.14B	92.32B	88.15B	90.47B	102B
Liabilities
Accounts Payable, Total	3.32B	4.12B	4.13B	3.78B	4.35B
Accrued Expenses, Total	7.87B	9.11B	12.25B	11.43B	12.8B
Short-term Borrowings	1.58B	500M	1.76B	848M	180M
Current Portion of Long-Term Debt	2.42B	14.62B	2.36B	3.62B	3.78B
Current Portion of Leases	319M	329M	302M	291M	325M
Current Income Taxes Payable	3.68B	3B	3.19B	2.26B	2.92B
Unearned Revenue Current, Total	439M	560M	601M	614M	809M
Other Current Liabilities	5.78B	6.18B	2.65B	1.98B	1.86B
Total Current Liabilities	25.4B	38.42B	27.24B	24.82B	27.02B
Long-Term Debt	10.22B	16.08B	21.39B	24.81B	30.72B
Long-Term Leases	876M	1.02B	891M	1.28B	1.38B
Unearned Revenue Non Current	156M	246M	254M	227M	160M
Pension & Other Post Retirement Benefits	7.83B	6.1B	4.56B	4.38B	4.38B
Deferred Tax Liability Non Current	353M	628M	645M	593M	832M
Other Non Current Liabilities	1.53B	1.48B	1.16B	1.09B	1.15B
Total Liabilities	46.36B	63.97B	56.14B	57.2B	65.64B
Common Stock, Total	160M	160M	107M	107M	107M
Retained Earnings	45.57B	34.16B	38.94B	42.35B	43.84B
Comprehensive Income and Other	-9.39B	-9.83B	-11.05B	-13.14B	-12.18B
Total Common Equity	36.34B	24.49B	27.99B	29.32B	31.77B
Minority Interest	3.43B	3.86B	4.02B	3.95B	4.39B
Total Equity	39.77B	28.34B	32.02B	33.26B	36.16B
Total Liabilities And Equity	86.14B	92.32B	88.15B	90.47B	102B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	853M	800M	799M	797M	795M
ECS Total Common Shares Outstanding	853M	800M	799M	797M	795M
Book Value / Share	42.6	30.6	35.03	36.77	39.94
Tangible Book Value	15.08B	1.56B	7.49B	5.1B	6.59B
Tangible Book Value Per Share	17.67	1.95	9.37	6.39	8.28
Total Debt	15.41B	32.55B	26.7B	30.85B	36.38B
Net Debt	3.07B	19.52B	16.93B	20.34B	19.05B
Debt Equivalent of Unfunded Proj. Benefit Obligation	6.16B	4B	1.59B	1.94B	1.74B
Debt Equivalent Oper. Leases	752M	696M	696M	656M	640M
Minority Interest, Total (Incl. Fin. Div)	3.43B	3.86B	4.02B	3.95B	4.39B
Equity Method Investments, Total	2M	331M	300M	242M	258M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.35B	1.55B	1.95B	1.7B	1.61B
Inventories - Work In Process, Total	4.46B	5.84B	6.39B	5.62B	5.12B
Inventories - Finished Goods, Total	1.96B	1.2B	1.14B	1.18B	1.57B
Land - (BS)	1.35B	1.32B	1.25B	1.11B	1.16B
Buildings, Total	17.46B	18.18B	19.81B	17.93B	20.67B
Machinery, Total	15.62B	16.36B	16.78B	14.36B	15.11B
Full Time Employees	101K	101K	104K	104K	103K
Assets on Operating Lease - Gross	5.51B	5.64B	5.72B	5.56B	6.05B
Assets on Operating Lease - Accumulated Depreciation	-3.83B	-4.01B	-4.16B	-3.98B	-4.26B
Accumulated Allowance for Doubtful Accounts (Supple)	515M	538M	490M	440M	453M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	14.3B	13.93B	12.42B	11.5B	8.28B
Depreciation & Amortization - CF	2.81B	2.89B	2.91B	2.75B	2.68B
Amortization of Goodwill and Intangible Assets - (CF)	1.75B	1.56B	938M	716M	742M
Depreciation & Amortization, Total	4.56B	4.44B	3.84B	3.46B	3.42B
Amortization of Deferred Charges, Total - (CF)	9M	8M	4M	8M	9M
(Gain) Loss From Sale Of Asset	-239M	-496M	-612M	-558M	-616M
(Gain) Loss on Sale of Investments - (CF)	-171M	89M	85M	-5M	-35M
Asset Writedown & Restructuring Costs	1.15B	1.45B	2.89B	2.23B	5.74B
(Income) Loss On Equity Investments - (CF)	1M	2M	41M	32M	45M
Stock-Based Compensation (CF)	713M	663M	738M	830M	855M
Provision and Write-off of Bad Debts	54M	44M	3M	6M	34M
Other Operating Activities, Total	258M	1.84B	1.42B	-305M	1.2B
Change in Other Net Operating Assets	-2.06B	-994M	-2.42B	-1.11B	1.16B
Cash from Operations	18.57B	20.98B	18.42B	16.1B	20.09B
Capital Expenditure	-3.53B	-3.69B	-3.45B	-3.74B	-3.53B
Sale of Property, Plant, and Equipment	70M	61M	82M	173M	61M
Cash Acquisitions	-1.18B	-2.36B	-245M	-6.22B	-3.12B
Divestitures	-	7M	1M	559M	1.43B
Sale (Purchase) of Intangible assets	-3.16B	-856M	-1.1B	-907M	-1.48B
Investment in Marketable and Equity Securities, Total	-994M	363M	1.13B	-707M	-5B
Other Investing Activities, Total	-274M	-73M	51M	201M	246M
Cash from Investing	-9.07B	-6.55B	-3.54B	-10.64B	-11.39B
Short Term Debt Issued, Total	318M	-	1.29B	-	-
Long-Term Debt Issued, Total	341M	20.31B	8.44B	8.34B	7.92B
Total Debt Issued	659M	20.31B	9.74B	8.34B	7.92B
Short Term Debt Repaid, Total	-	-1.13B	-	-806M	-709M
Long-Term Debt Repaid, Total	-369M	-2.83B	-15.84B	-2.09B	-3.74B
Total Debt Repaid	-369M	-3.96B	-15.84B	-2.9B	-4.45B
Issuance of Common Stock	37M	-	-	-	-
Repurchase of Common Stock	-2.14B	-20.4B	-1.26B	-1.14B	-1.13B
Common Dividends Paid	-7.7B	-7.77B	-7.45B	-7.59B	-7.65B
Common & Preferred Stock Dividends Paid	-7.7B	-7.77B	-7.45B	-7.59B	-7.65B
Other Financing Activities, Total	-157M	-1.29B	-1.47B	-951M	-1.51B
Cash from Financing	-9.67B	-13.11B	-16.28B	-4.24B	-6.82B
Foreign Exchange Rate Adjustments	-181M	-193M	-463M	-828M	-283M
Net Change in Cash	-348M	1.12B	-1.86B	385M	1.6B
Supplemental Items
Cash Interest Paid	422M	405M	557M	770M	1.14B
Cash Income Tax Paid (Refund)	3.24B	3.34B	4.1B	3.62B	3.73B
Levered Free Cash Flow	8.42B	12.89B	11.32B	8.6B	13.67B
Unlevered Free Cash Flow	8.68B	13.1B	11.69B	9.11B	14.44B
Change In Net Working Capital	2.21B	116M	1.58B	1.64B	-2.91B
Net Debt Issued / Repaid	290M	16.35B	-6.1B	5.45B	3.47B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	14.55	14.19	14.68	12.44	12.75
Return on Total Capital	23.09	21.81	22.14	18.09	17.94
Return On Equity %	39.84	43.85	44.83	37.86	26.47
Return on Common Equity	41.38	45.8	47.34	40.13	27.1
Margin Analysis
Gross Profit Margin %	73.72	70.6	72	74.19	74.79
SG&A Margin	19.81	18.19	18.14	22.31	21.92
EBITDA Margin %	39.6	36.95	37.17	34.61	36.41
EBITA Margin %	35.54	33.12	33.31	30.6	32.63
EBIT Margin %	32.64	30.76	31.9	29.42	31.44
Income From Continuing Operations Margin %	24.97	22.68	20.37	20.45	14.72
Net Income Margin %	23.69	21.15	18.7	19.02	13.27
Net Avail. For Common Margin %	23.69	21.15	18.7	19.02	13.27
Normalized Net Income Margin	18.46	17.15	17.34	16.01	16.85
Levered Free Cash Flow Margin	13.95	19.58	17.04	14.24	21.9
Unlevered Free Cash Flow Margin	14.39	19.89	17.6	15.08	23.14
Asset Turnover
Asset Turnover	0.71	0.74	0.74	0.68	0.65
Fixed Assets Turnover	2.59	2.76	2.73	2.56	2.67
Receivables Turnover (Average Receivables)	5.64	6.02	5.64	4.94	5.15
Inventory Turnover (Average Inventory)	2.39	2.6	2.28	1.91	2.05
Short Term Liquidity
Current Ratio	1.3	0.93	1.24	1.35	1.48
Quick Ratio	0.95	0.67	0.86	0.94	1.14
Operating Cash Flow to Current Liabilities	0.73	0.55	0.68	0.65	0.74
Days Sales Outstanding (Average Receivables)	64.91	60.67	64.73	73.83	71
Days Outstanding Inventory (Average Inventory)	152.86	140.54	160.15	191.36	178.63
Average Days Payable Outstanding	69.9	71.17	77.23	98	95.51
Cash Conversion Cycle (Average Days)	147.88	130.04	147.64	167.19	154.11
Long Term Solvency
Total Debt/Equity	38.75	114.84	83.4	92.75	100.6
Total Debt / Total Capital	27.93	53.45	45.47	48.12	50.15
LT Debt/Equity	27.9	60.33	69.6	78.44	88.76
Long-Term Debt / Total Capital	20.11	28.08	37.95	40.7	44.25
Total Liabilities / Total Assets	53.83	69.3	63.68	63.23	64.48
EBIT / Interest Expense	44.97	59.22	34.85	21.47	15.72
EBITDA / Interest Expense	55.38	72.21	41.17	25.66	18.46
(EBITDA - Capex) / Interest Expense	47.32	61.41	35.5	21.14	15.63
Total Debt / EBITDA	0.64	1.32	1.07	1.45	1.58
Net Debt / EBITDA	0.13	0.79	0.68	0.96	0.83
Total Debt / (EBITDA - Capex)	0.74	1.55	1.24	1.76	1.86
Net Debt / (EBITDA - Capex)	0.15	0.93	0.78	1.16	0.98
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.35	9.13	0.87	-8.16	3.23
Gross Profit, 1 Yr. Growth %	-4.06	4.51	2.88	-6.33	4.06
EBITDA, 1 Yr. Growth %	-4.31	1.82	1.47	-13.1	8.6
EBITA, 1 Yr. Growth %	-4.95	1.69	1.45	-14	10.08
EBIT, 1 Yr. Growth %	-6.35	2.82	4.61	-13.56	10.34
Earnings From Cont. Operations, 1 Yr. Growth %	6.8	-0.88	-9.4	-8.67	-25.66
Net Income, 1 Yr. Growth %	5.91	-2.55	-10.83	-7.43	-28.01
Normalized Net Income, 1 Yr. Growth %	-7.6	1.34	1.99	-13.11	8.63
Diluted EPS Before Extra, 1 Yr. Growth %	5.8	-1.99	-5.1	-6.9	-27.95
Accounts Receivable, 1 Yr. Growth %	-3.01	7.72	7.52	-5.4	3.25
Inventory, 1 Yr. Growth %	18.81	7.24	11.54	-9.95	-1.85
Net Property, Plant and Equip., 1 Yr. Growth %	-0.21	4.91	-0.84	-5.24	3.49
Total Assets, 1 Yr. Growth %	3.67	7.17	-4.51	2.63	12.53
Tangible Book Value, 1 Yr. Growth %	28.84	-89.63	379.01	-31.92	29.25
Common Equity, 1 Yr. Growth %	10.98	-32.61	14.3	4.73	8.36
Cash From Operations, 1 Yr. Growth %	-17.06	12.98	-12.21	-9.59	24.85
Capital Expenditures, 1 Yr. Growth %	0.71	4.68	-6.61	8.5	-5.69
Levered Free Cash Flow, 1 Yr. Growth %	-40.98	53.17	-12.08	-21.29	58.83
Unlevered Free Cash Flow, 1 Yr. Growth %	-40.68	50.87	-10.59	-19.4	58.41
Dividend Per Share, 1 Yr. Growth %	1.11	2.2	2.15	1.05	1.04
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.71	1.63	4.92	-4.2	-2.63
Gross Profit, 2 Yr. CAGR %	1.74	0.13	3.69	-1.79	-1.27
EBITDA, 2 Yr. CAGR %	3.05	-1.29	1.64	-7.28	-2.86
EBITA, 2 Yr. CAGR %	3.01	-1.69	1.57	-7.91	-2.71
EBIT, 2 Yr. CAGR %	2.04	-1.87	3.71	-6.31	-2.34
Earnings From Cont. Operations, 2 Yr. CAGR %	17.76	2.89	-5.24	-9.04	-17.6
Net Income, 2 Yr. CAGR %	16.68	1.59	-6.78	-9.15	-18.37
Normalized Net Income, 2 Yr. CAGR %	0.77	-3.21	1.67	-7.45	-2.84
Diluted EPS Before Extra, 2 Yr. CAGR %	16.34	1.83	-3.55	-6	-18.1
Accounts Receivable, 2 Yr. CAGR %	1.42	2.22	7.62	0.86	-1.17
Inventory, 2 Yr. CAGR %	4.24	12.88	9.37	0.22	-5.98
Net Property, Plant and Equip., 2 Yr. CAGR %	3.27	2.32	2	-3.06	-0.97
Total Assets, 2 Yr. CAGR %	4.74	5.41	1.16	-1.01	7.46
Tangible Book Value, 2 Yr. CAGR %	27.13	-63.45	-29.53	80.58	-6.2
Common Equity, 2 Yr. CAGR %	14.7	-13.52	-12.24	9.41	6.53
Cash From Operations, 2 Yr. CAGR %	-3.6	-3.2	-0.41	-12.4	6.24
Capital Expenditures, 2 Yr. CAGR %	-6.59	2.68	-1.13	0.66	1.15
Levered Free Cash Flow, 2 Yr. CAGR %	-17.53	-4.92	15.95	-18.25	11.81
Unlevered Free Cash Flow, 2 Yr. CAGR %	-17.46	-5.4	16.05	-16.52	13
Dividend Per Share, 2 Yr. CAGR %	2.27	1.65	2.17	1.6	1.05
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.68	3.44	1.38	0.05	-1.78
Gross Profit, 3 Yr. CAGR %	3.73	2.65	1.04	0.27	0.12
EBITDA, 3 Yr. CAGR %	4.1	2.64	-0.38	-4.34	-2.26
EBITA, 3 Yr. CAGR %	4.14	2.57	-0.65	-4.82	-2.27
EBIT, 3 Yr. CAGR %	4.42	2.3	0.24	-3.36	-1.06
Earnings From Cont. Operations, 3 Yr. CAGR %	19.52	11.19	-1.38	-6.4	-14.95
Net Income, 3 Yr. CAGR %	18.31	9.88	-2.73	-7	-15.93
Normalized Net Income, 3 Yr. CAGR %	3.06	0.97	-1.5	-4.61	-2.37
Diluted EPS Before Extra, 3 Yr. CAGR %	18.08	9.88	-0.53	-4.68	-13.98
Accounts Receivable, 3 Yr. CAGR %	1.54	3.48	3.96	3.09	1.65
Inventory, 3 Yr. CAGR %	-0.97	5.23	12.43	2.51	-0.47
Net Property, Plant and Equip., 3 Yr. CAGR %	3.63	3.82	1.26	-0.48	-0.93
Total Assets, 3 Yr. CAGR %	3.95	5.55	1.99	1.65	3.31
Tangible Book Value, 3 Yr. CAGR %	23.54	-44.87	-13.83	-30.33	61.53
Common Equity, 3 Yr. CAGR %	11.18	-3.93	-5.1	-6.91	9.06
Cash From Operations, 3 Yr. CAGR %	0.99	1.64	-6.3	-4.65	-1.42
Capital Expenditures, 3 Yr. CAGR %	0.18	-2.97	-0.52	1.98	-1.5
Levered Free Cash Flow, 3 Yr. CAGR %	-12.07	1.37	-7.42	0.73	2.01
Unlevered Free Cash Flow, 3 Yr. CAGR %	-12	0.92	-7.21	1.63	3.35
Dividend Per Share, 3 Yr. CAGR %	3.11	2.25	1.82	1.8	1.41
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.67	4.58	3.57	0.32	-0.43
Gross Profit, 5 Yr. CAGR %	4.23	4.36	3.71	0.85	0.13
EBITDA, 5 Yr. CAGR %	4.64	3.33	3.11	-1.45	-1.88
EBITA, 5 Yr. CAGR %	4.6	3.2	3.1	-1.76	-2.04
EBIT, 5 Yr. CAGR %	4.97	3.75	4.14	-1.24	-1.38
Earnings From Cont. Operations, 5 Yr. CAGR %	10.72	8.94	8.92	2.61	-8.22
Net Income, 5 Yr. CAGR %	10.03	7.78	7.55	1.83	-9.32
Normalized Net Income, 5 Yr. CAGR %	5.24	2.84	2.51	-2.48	-2.71
Diluted EPS Before Extra, 5 Yr. CAGR %	9.96	7.78	8.9	3.23	-7.97
Accounts Receivable, 5 Yr. CAGR %	5.14	5.61	3.93	2.42	1.87
Inventory, 5 Yr. CAGR %	-1.22	-0.54	3.04	3.2	4.67
Net Property, Plant and Equip., 5 Yr. CAGR %	4.73	4.11	2.97	1.01	0.36
Total Assets, 5 Yr. CAGR %	2.6	3.74	2.83	2.87	4.15
Tangible Book Value, 5 Yr. CAGR %	30.62	21.8	-1.31	-11.39	-10.85
Common Equity, 5 Yr. CAGR %	11.62	0.48	1.15	1.2	-0.61
Cash From Operations, 5 Yr. CAGR %	4.01	6.94	0.43	-4.23	-2.14
Capital Expenditures, 5 Yr. CAGR %	0.34	-2.28	-0.34	-1.54	0.15
Levered Free Cash Flow, 5 Yr. CAGR %	-4.01	9.2	-1.78	-7.01	-0.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	-4.38	8.46	-1.7	-6.49	-0.27
Dividend Per Share, 5 Yr. CAGR %	2.36	2.55	2.74	1.99	1.51